ExAdEx-Innov at Cosmetic-360 2024 in Paris
septembre 25, 2024
Let’s explore innovation at the 10th edition of COSMETIC 360 tradeshow in Paris in October 2024! We are pleased to announce our participation in the
We are excited to announce that our scientific research work performed in collaboration with our partner Exsymol Monaco, titled A Novel Micro-Physiological Model of Native Adipose Tissue for Assessing the Ability of a Silicium-Caffeine Complex to Prevent Fibro-Inflammation in Cellulite, will be presented during the poster session of the IFSCC Congress 2024—a premier event for dermo-cosmetic research worldwide.
Attendees are invited to visit our poster to engage in discussions and explore the latest advancements in ex vivo dermo-cosmetic research. We are eager to share our findings with industry professionals, researchers and enthusiasts. Join us to discover how we are shaping the future of dermo-cosmetic research.
🌍 WHERE: Iguazu Falls, Brazil
🗓️ WHEN: Wed 16th October 2024, 10:30-11:00 & Thu 17th October 2024, 12:00-13:20
📌 POSTER ID: SHO 200 – Exhibition Area Groups 7/8
For more information about the exhibition, please visit the exhibition website here
Let’s explore innovation at the 10th edition of COSMETIC 360 tradeshow in Paris in October 2024! We are pleased to announce our participation in the
Organoid models developed by ExAdEx-Innov and collaborators presented at the 3R LÄND CONFERENCE 2024 in Tübingen (Germany) Latest work from ExAdEx-Innov team on clinically relevant
Scientific work performed by ExAdEx-Innov researchers and collaborators will be presented during European Congress on Obesity ECO 2024 Latest work on adipose tissue and obesity
Copyright © 2022 ExAdEx-Innov All rights reserved
KOL on adipose tissue biology.
Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice).
Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program).
Co-inventor of 5 patents
Expert in clinical applications of adipose tissue.
Plastic Reconstructive and Aesthetic Surgeon in Nice.
Member of the Medical Council of Alpes Maritimes region.
Expert for the French National Regulatory Agency ANSM for medical devices.
Certified by French Health Autority HAS (2020-2024).
PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.
Expert in cell therapy and immunology.
Senior Lecturer (Maitre de conférences).
Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).
Director of « Micoralis » research team at Université Côte d’Azur (Nice).
Founder and CEO of the biotech company Biointerférence (2003-2006).
Co-inventor of 5 patents.
Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.
With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov.
In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille).
He is co-inventor of the 2 company’s patent families.
Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue.
Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.
With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years.
He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.
Main areas of expertise: Biotech Startup Business Development; Project management